October 17th, 2007 - Vivalis (Euronext : VLS) announces having granted rights to SANOFI-AVENTIS to evaluate EBx® cell lines, cell substrates derived from avian embryonic stem cells, for the production of monoclonal antibodies... Vivalis' Press Release-Thursday, October 18, 2007
VIVALIS , FIRST RESEARCH LICENCE IN THE FIELD OF THERAPEUTIC PROTEINS WITH SANOFI-AVENTIS
October 17th, 2007 - Vivalis (Euronext : VLS) announces having granted rights to SANOFI-AVENTIS to evaluate EBx® cell lines, cell substrates derived from avian embryonic stem cells, for the production of monoclonal antibodies... Vivalis' Press Release-
